Edit

EMBL scientists found start-up company to develop anti-cancer drugs

Today EMBL scientists, EMBL’s commercial affiliate, EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) and EMBL’s venture…

By Guest author(s)

Lab Matters

Alleviating the burden of Multiple Sclerosis

Depression, coordination and speech problems, muscle weakness and disability are just a few of the symptoms of Multiple Sclerosis (MS). Researchers…

By Guest author(s)

Science

EMBL-EBI and collaborators win bid to run UK PubMed Central

Scientists will be able to access a vast collection of biomedical research at the touch of a button thanks to a major new initiative that aims to…

By Guest author(s)

Lab Matters

Mapping the protein world

In the early days of X-ray crystallography obtaining a three-dimensional model of a protein required wire models, screws, bolts and years of tedious…

By Guest author(s)

Lab Matters

Croatia becomes EMBL’s 19th Member State

Croatia has officially joined the European Molecular Biology Laboratory (EMBL) as the organisation’s 19th Member State. The Croatian…

By Guest author(s)

Lab Matters

Cracking a virus protection shield

Ebola, measles and rabies are serious threats to public health in developing countries. Despite different symptoms all of the diseases are caused by…

By Guest author(s)

Science

New potential drug target in tuberculosis

Tuberculosis remains one of the deadliest threats to public health. Every year two million people die of the disease, which is caused by the…

By Guest author(s)

Science

Free access to world-class biological databases for European science thanks to FELICS

Today the European Molecular Biology Laboratory’s (EMBL) European Bioinformatics Institute (EBI), the Swiss Institute for Bioinformatics (SIB),…

By Guest author(s)

Lab Matters

A brighter future for Europe’s favourite molecular biology software package

EMBOSS, the European Molecular Biology Open Software Suite, has received a vital funding boost from the UK Biotechnology and Biological Sciences…

By Guest author(s)

Lab Matters

Getting to the heart of cardiovascular diseases

Today three research organisations announce the merging of their expertise to fight cardiovascular diseases, which are among the most common health…

By Guest author(s)

Lab Matters

With joint forces against Malaria

Today the network of excellence for Biology and Pathology of the Malaria Parasite (BioMalPar), will bring together the world’s elite in the…

By Guest author(s)

Events

Bringing science out of the lab into the classroom

Science is moving more rapidly than ever; one groundbreaking discovery chases the next at an incredible speed. School teachers have trouble keeping…

By Guest author(s)

Lab Matters

EMBLetc.

Read the latest Issues of our magazine - EMBLetc.

Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.

EMBLetc. archive

Newsletter archive

Read past editions of our monthly e-newsletter

For press

Contact the Press Office
Edit